Panic Disorder - Acute and Long Term Care

Key Points

• Panic disorder requires recurrent unexpected attacks plus persistent concern or behavioral change, not a single panic attack.
• A first or atypical attack requires medical risk assessment before attributing symptoms to anxiety.
• Panic-focused CBT uses interoceptive and situational exposure rather than reassurance alone.
• SSRIs and SNRIs are first-line maintenance medications and often need low starting doses.
• Benzodiazepines may relieve symptoms rapidly but can create dependence and interfere with exposure-based recovery when used chronically.
• Agoraphobic avoidance should be assessed directly because it often determines disability.
• Treat comorbid depression, PTSD, substance use, and suicidality as part of the same care plan.
• Measure success by reduced attacks, reduced anticipatory anxiety, and restored activity.

Algorithm

1. Assess airway, breathing, circulation, vital signs, glucose, and red flags during an acute episode.
2. Use history, examination, ECG, and targeted testing to exclude cardiopulmonary, endocrine, neurologic, or toxicologic mimics.
3. After medical stabilization, determine whether attacks are recurrent and unexpected and whether persistent concern or avoidance is present.
4. Assess agoraphobia, depression, suicidality, bipolar symptoms, and substance use.
5. Offer panic-focused CBT and/or an SSRI/SNRI.
6. Start antidepressants low and titrate gradually while warning about transient activation.
7. Reassess avoidance and functional recovery, not just attack frequency.
8. Continue effective treatment through remission and taper gradually with relapse-prevention exposure skills.

Clinical Synopsis & Reasoning

A panic attack is an abrupt surge of intense fear or discomfort that peaks within minutes and may include palpitations, sweating, tremor, dyspnea, choking sensation, chest discomfort, nausea, dizziness, chills or heat, paresthesias, derealization, fear of losing control, or fear of dying. Panic disorder requires recurrent unexpected attacks plus at least a month of persistent concern about additional attacks or maladaptive behavioral change. The distinction between expected attacks in a phobic situation and truly unexpected attacks matters diagnostically. Agoraphobic avoidance may become more disabling than the attacks themselves.

The first presentation, an atypical episode, late onset, syncope, exertional symptoms, focal neurologic findings, persistent hypoxemia, fever, or abnormal vital signs should trigger evaluation for a medical cause. Important mimics include acute coronary syndrome, pulmonary embolism, arrhythmia, asthma, hypoglycemia, hyperthyroidism, seizure, vestibular disease, stimulant intoxication, cannabis effects, alcohol or benzodiazepine withdrawal, and medication toxicity. A focused ECG, glucose, pregnancy testing, thyroid testing, cardiopulmonary evaluation, or toxicology workup is driven by risk and findings. Once dangerous causes are excluded, explaining the physiology of panic can itself reduce catastrophic misinterpretation. Assess depression, suicidality, substance use, PTSD, social anxiety, OCD, and bipolar disorder because these alter the treatment plan.

Treatment Strategy & Disposition

During an acute panic attack, place the patient in a calm environment, validate that the symptoms are real, coach slow regular breathing, and avoid reinforcing catastrophic explanations. Pharmacologic rescue is rarely the central solution after a medical emergency has been excluded. A short-acting benzodiazepine can reduce acute symptoms in selected patients, but routine reliance can reinforce avoidance, impair exposure-based learning, and produce tolerance or dependence. Recurrent emergency visits should prompt a longitudinal plan rather than repeated sedative treatment.

For maintenance, panic-focused CBT and an SSRI or SNRI are first-line approaches. CBT typically combines psychoeducation, cognitive restructuring, interoceptive exposure to feared bodily sensations, in-vivo exposure to avoided situations, and reduction of safety behaviors. Antidepressants should usually be started at a lower dose than might be used for uncomplicated depression because early activation can be particularly difficult for patients who catastrophize physiologic sensations. Titrate gradually and allow an adequate trial. If effective, continue through sustained remission before a slow taper. If response is incomplete, assess adherence, dose, duration, avoidance patterns, substance use, and whether exposure work has actually occurred. Switch to another first-line medication or intensify evidence-based psychotherapy before using complex polypharmacy.

Epidemiology / Risk Factors

• Panic disorder often begins in adolescence or early adulthood and can follow an episodic or chronic course.
• Agoraphobia may coexist and substantially increase functional impairment.
• First-degree relatives of affected patients have increased risk, reflecting genetic and environmental contributions.
• Caffeine, stimulants, cannabis, and withdrawal states can precipitate or mimic attacks.

Investigations

Education Points

Pharmacology

Prognosis / Complications

• Evidence-based CBT and antidepressant therapy produce meaningful improvement for many patients.
• Untreated anticipatory anxiety can progressively narrow travel, work, exercise, and social activity.
• Relapse can occur after abrupt medication discontinuation or when exposure-based gains are not maintained.
• Comorbid depression, substance misuse, and agoraphobia are associated with a more complicated course.

Patient Education / Counseling

• Explain that panic sensations are intense but time-limited once dangerous medical causes have been excluded.
• Teach a plan for staying in the situation long enough to allow anxiety to fall instead of escaping at the first symptom.
• Reduce excess caffeine and avoid using alcohol or sedatives to prevent attacks.
• If a benzodiazepine is used, define the purpose, duration, safety restrictions, and taper plan from the outset.
• Provide urgent-care instructions for symptoms that are new, exertional, associated with syncope, persistent hypoxemia, focal deficits, or suicidality.

Notes

A common treatment failure is focusing exclusively on attack suppression. Patients may report fewer attacks because they have stopped driving, exercising, shopping, or being alone. That is not recovery. Follow-up should ask what activities have resumed and which sensations or settings remain feared. Structured exposure work is especially important when agoraphobia is present.

Panic symptoms can coexist with real medical disease. A patient with a known panic disorder still deserves reassessment when the quality of symptoms changes, when objective abnormalities appear, or when new risk factors emerge. The goal is neither indiscriminate testing nor reflexive psychologizing, but a consistent method that recognizes emergencies and then treats panic disorder directly.

References

1. NICE CG113: Generalised anxiety disorder and panic disorder in adults — Link